Should You Buy Actinium Pharmaceuticals Inc (ATNM) Stock Thursday Morning?

Actinium Pharmaceuticals Inc (ATNM) is higher by Thursday morning, with the stock rising 2.75% in pre-market trading to 6.35. ATNM's short-term technical score of 76 indicates that the stock has traded more bullishly over the last month than 76% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, ATNM ranks higher than 83% of stocks. Actinium Pharmaceuticals Inc has risen 26.38% over the past month, closing at $4.88 on July 28. During this period of time, the stock fell as low as $4.81 and as high as $6.25. ATNM has an average analyst recommendation of Strong Buy. The company has an average price target of $31.67.

ATNM has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on ATNM!

See Full ATNM Report

Actinium Pharmaceuticals Inc has a Long-Term Technical rank of 69. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 31% of the market scoring higher. In the Biotechnology industry which is number 72 by this metric, ATNM ranks better than 72% of stocks.

Important Dates for Investors in ATNM:

-Actinium Pharmaceuticals Inc is set to release earnings on 11/10/2022. Over the last 12 months, the company has reported EPS of $-1.22. -We do not have a set dividend date for Actinium Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Actinium Pharmaceuticals Inc (ATNM)